136
Views
0
CrossRef citations to date
0
Altmetric
Oncology

High Expression of MORC2 is Associated with Poor Clinical Outcomes and Immune Infiltrates in Colon Adenocarcinoma

, , , , & ORCID Icon
Pages 4595-4615 | Received 20 May 2023, Accepted 07 Sep 2023, Published online: 11 Oct 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.